<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27556312</article-id><article-id pub-id-type="pmc">5062736</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20160037</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Is Age a Determinant Factor in EVAR as a Predictor of Outcomes or in
the Selection Procedure? Our Experience</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Machado</surname><given-names>Rui</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Teixeira</surname><given-names>Gabriela</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Oliveira</surname><given-names>Pedro</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Loureiro</surname><given-names>Lu&#x000ed;s</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Carlos</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Almeida</surname><given-names>Rui</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Hospital de Santo Ant&#x000f3;nio - Centro Hospitalar do
Porto, Porto, Portugal</aff><aff id="aff2"><label>2</label>Instituto de Ci&#x000ea;ncias Biom&#x000e9;dicas Abel
Salazar (ICBAS), Porto, Portugal</aff><author-notes><corresp id="c1">Correspondence Address: Gabriela Teixeira, Hospital de Santo
Ant&#x000f3;nio - Centro Hospitalar do Porto, Largo Professor Abel Salazar,
4099-001 - Porto, Portugal. E-mail: <email>tgabrielateixeira@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2016</year></pub-date><volume>31</volume><issue>2</issue><fpage>132</fpage><lpage>139</lpage><history><date date-type="received"><day>20</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Endovascular aneurysm repair (EVAR) is the therapy of choice in high risk
patients with abdominal aortic aneurysm. The good results described are
leading to the broadening of clinical indications to younger patients.
However, reintervention rates seem higher and even with successful treatment
sometimes there is growth of the aneurysm sac and rupture, meaning a failure
of the therapeutic goal. This study proposes to analyse the impact of age in
patients' selection and post-EVAR results.</p></sec><sec><title>Methods</title><p>The clinical records of consecutive patients undergoing endovascular aneurysm
repair, between 2001 and 2013, were retrospectively reviewed. Patients were
divided according to age groups (&#x0003c;70, 70-80 and &#x0003e;80 years). Gender,
body mass index, aneurysm anatomic features, neck characteristics, iliac
morphology, surgical indication, endograft type, anesthesic risk
classification, length of stay, reinterventions and mortality were analysed
and compared.</p></sec><sec><title>Results</title><p>The study included 171 patients, 161 (94.1%) men, and mean age
74.1&#x000b1;8.9 years. The age group under 70 had 32% of the patients. Only
three characteristics were found different among age groups: 1) body mass
index was higher in younger patients, with a considerable trend toward
significance (P=0.06); 2) surgical indication, in the younger group,
surgeon's and the patient's option were more proeminent
(<italic>P</italic>&#x0003c;0.05); 3) erectile dysfunction was higher in elderly
group (<italic>P</italic>&#x0003c;0.05). No other clinical and anatomical
characteristics or final outcomes were found statisticaly different among
age groups.</p></sec><sec><title>Conclusion</title><p>The absence of statistically differences in mortality and reinterventions
among age groups suggests that age by itself is not a relevant factor in
endovascular aneurysm repair. Indeed, the three characteristics different in
younger (obesity, sexual function and patient's choice) favor endovascular
aneurysm repair.</p></sec></abstract><kwd-group><kwd>Age Groups</kwd><kwd>Aortic Aneurysm, Abdominal</kwd><kwd>Endovascular Procedures</kwd></kwd-group></article-meta></front><body><table-wrap id="t8" orientation="portrait" position="anchor"><table frame="hsides" rules="groups" style="background-color:#e6e7e8"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">AAA</td><td rowspan="1" colspan="1">= Abdominal aortic aneurysm</td></tr><tr><td rowspan="1" colspan="1">ASA</td><td rowspan="1" colspan="1">= American Society of Anesthesiologists</td></tr><tr><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">= Body mass index</td></tr><tr><td rowspan="1" colspan="1">EVAR</td><td rowspan="1" colspan="1">= Endovascular aneurysm repair</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Since Parodi's publication in 1991 about the first endovascular aneurysm repair
(EVAR)<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>, this therapy has
been widely used in elderly and high-risk patients. Several randomized controlled
trials showed less mortality, a shorter length of stay, lower consumption of blood
products, and a better short-term quality of life with EVAR<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r5" ref-type="bibr">5</xref>]</sup>. When it comes to younger patients, it is imperative to
question the procedure's durability, reintervention rates, and the probability of
aneurysm sac growth and rupture. The purpose of this study is to investigate if
there is any association of age during EVAR, clinical characteristics of the
patients and the outcomes of the procedure compared among different age groups.</p></sec><sec sec-type="methods"><title>METHODS</title><p>The clinical records of consecutive patients undergoing EVAR for infrarenal abdominal
aortic aneurysm (AAA) or aortoiliac aneurysms between October 2001 and December 2013
in our department were retrospectively reviewed. All surgeries took place in an
operation room equipped with a Philips BV 300 C-Arm and a radiolucent table, and
were performed by the same surgical team. The surgical criteria were infra-renal
fusiforme AAA with diameter equal or superior to 5 cm and AAA associated with iliac
aneurysms with diameter equal or superior to 3 cm, saccular aneurysms and false
aneurysms. The endografts used were Talent Bi- and Uni-Iliac (suprarenal fixation,
by friction) and Gore-Excluder Bi-Iliac (infrarenal fixation, by barbs); after
October 2008 the Endurant Bi- and Uni-Iliac (suprarenal fixation, by hooks) were
used. Patients were divided by age. The groups were: patients younger than 70 years
old, 70 to 80 years old and older. Sex, atherosclerotic risk factors (hypertension,
diabetes, smoke history, dyslipidemia), cerebrovascular disease, peripheral arterial
disease, body mass index (BMI), anatomic features, aneurysm diameter, neck
characteristics (diameter, angulation, length, calcification, thrombus), iliac
morphology (tortuosity and diameter), anatomical risks, internal iliac artery
aneurysm, surgical indication for EVAR, endograft type, American Society of
Anesthesiologists (ASA) classification, anesthetic technique, length of stay,
re-interventions, mortality, and costs were analyzed and compared.</p><sec><title>Statistical Analysis</title><p>Statistical analysis included t-tests for two independent samples, analyses of
variance in the case of several groups, and chi-square tests for the comparison
of categorical variables. Nonparametric tests were used when the normality or
homogeneity of variances was not observed. All the analyses were performed using
IBM SPSS Statistics, version 22; the statistical significance of two-sided tests
was assumed to be <italic>P</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>One hundred and seventy-one patients, of which 94.2% (161/171) were men, underwent
EVAR. The mean age was 74.1 years and the median was 75, with a standard deviation
of 8.9 (min.: 38; max.: 93). The under-70 age group had 32% of the patients, 38.4%
were between 70 and 80 years old, and 29.7% were more than 80 years old. The median
time of follow-up was 32.7&#x000b1;29.8 months.</p><p>Pre-, intra-, and postoperative data are shown in <xref ref-type="table" rid="t1">Table 1</xref>. Atherosclerotic risk factors, cerebrovascular and peripheral
arterial disease and BMI are shown in <xref ref-type="table" rid="t2">Table
2</xref>. Younger patients had a higher BMI, near to statistical significance
(<italic>P</italic>=0.06).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Pre, intra and postoperative data. No statistical significance. IIA, Internal
Iliac Artery; CIA, Common Iliac Artery; ASA, American Society of
Anaesthesiologists classification.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/><col width="0,5%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th colspan="60" align="center" rowspan="1">&#x0003c; 70 years</th><th colspan="60" align="center" rowspan="1">&#x0003c; 70 years</th><th colspan="60" align="center" rowspan="1">&#x0003c; 70 years</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1">Aneurysm Morphology</td><td colspan="15" align="center" rowspan="1">Aortic</td><td colspan="15" align="center" rowspan="1">Right AortoIliac</td><td colspan="15" align="center" rowspan="1">Left AortoIliac</td><td colspan="15" align="center" rowspan="1">Bilateral AortoIliac</td><td colspan="15" align="center" rowspan="1">Aortic</td><td colspan="15" align="center" rowspan="1">Right AortoIliac</td><td colspan="15" align="center" rowspan="1">Left AortoIliac</td><td colspan="15" align="center" rowspan="1">Bilateral AortoIliac</td><td colspan="15" align="center" rowspan="1">Aortic</td><td colspan="15" align="center" rowspan="1">Right AortoIliac</td><td colspan="15" align="center" rowspan="1">Left AortoIliac</td><td colspan="15" align="center" rowspan="1">Bilateral AortoIliac</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="15" align="center" rowspan="1">30.4%</td><td colspan="15" align="center" rowspan="1">34.6%</td><td colspan="15" align="center" rowspan="1">38.5%</td><td colspan="15" align="center" rowspan="1">30%</td><td colspan="15" align="center" rowspan="1">41.1%</td><td colspan="15" align="center" rowspan="1">30.8%</td><td colspan="15" align="center" rowspan="1">53.8%</td><td colspan="15" align="center" rowspan="1">45%</td><td colspan="15" align="center" rowspan="1">28.6%</td><td colspan="15" align="center" rowspan="1">34.6%</td><td colspan="15" align="center" rowspan="1">7.7%</td><td colspan="15" align="center" rowspan="1">45%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">IIA Aneurysm</td><td colspan="60" align="center" rowspan="1">5.8%</td><td colspan="60" align="center" rowspan="1">12.1%</td><td colspan="60" align="center" rowspan="1">12%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Aneurysm Diameter</td><td colspan="60" align="center" rowspan="1">61.7mm (min 27 ; max 104)</td><td colspan="60" align="center" rowspan="1">61.2mm (min 30 ; max 106)</td><td colspan="60" align="center" rowspan="1">64.5 (min 25 ; max 103)</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Neck Diameter</td><td colspan="60" align="center" rowspan="1">22mm (min 16 ; max 30)</td><td colspan="60" align="center" rowspan="1">22.8 (min 18 ; max 33)</td><td colspan="60" align="center" rowspan="1">22.8mm (min 16 ; max 32)</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Neck Length</td><td colspan="60" align="center" rowspan="1">22.5 (min 10 ; max 70)</td><td colspan="60" align="center" rowspan="1">22.9mm (min 10 ; max 80)</td><td colspan="60" align="center" rowspan="1">23.6mm (min 6 ; max 50)</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1">Neck Shape</td><td colspan="15" align="center" rowspan="1">Straight</td><td colspan="15" align="center" rowspan="1">Conical</td><td colspan="15" align="center" rowspan="1">Inverted</td><td colspan="15" align="center" rowspan="1">Other</td><td colspan="15" align="center" rowspan="1">Straight</td><td colspan="15" align="center" rowspan="1">Conical</td><td colspan="15" align="center" rowspan="1">Inverted</td><td colspan="15" align="center" rowspan="1">Other</td><td colspan="15" align="center" rowspan="1">Straight</td><td colspan="15" align="center" rowspan="1">Conical</td><td colspan="15" align="center" rowspan="1">Inverted</td><td colspan="15" align="center" rowspan="1">Other</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="15" align="center" rowspan="1">62%</td><td colspan="15" align="center" rowspan="1">28%</td><td colspan="15" align="center" rowspan="1">6%</td><td colspan="15" align="center" rowspan="1">4%</td><td colspan="15" align="center" rowspan="1">61.4%</td><td colspan="15" align="center" rowspan="1">29.8%</td><td colspan="15" align="center" rowspan="1">3.5%</td><td colspan="15" align="center" rowspan="1">5.3%</td><td colspan="15" align="center" rowspan="1">69.8%</td><td colspan="15" align="center" rowspan="1">26.5%</td><td colspan="15" align="center" rowspan="1">4.7%</td><td colspan="15" align="center" rowspan="1">0%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1">Calcification</td><td colspan="20" align="center" rowspan="1">&#x0003c;50%</td><td colspan="20" align="center" rowspan="1">&#x0003e;50%</td><td colspan="20" align="center" rowspan="1">None</td><td colspan="20" align="center" rowspan="1">&#x0003c;50%</td><td colspan="20" align="center" rowspan="1">&#x0003e;50%</td><td colspan="20" align="center" rowspan="1">None</td><td colspan="20" align="center" rowspan="1">&#x0003c;50%</td><td colspan="20" align="center" rowspan="1">&#x0003e;50%</td><td colspan="20" align="center" rowspan="1">None</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="20" align="center" rowspan="1">75%</td><td colspan="20" align="center" rowspan="1">25%</td><td colspan="20" align="center" rowspan="1">0%</td><td colspan="20" align="center" rowspan="1">68.3%</td><td colspan="20" align="center" rowspan="1">26.7%</td><td colspan="20" align="center" rowspan="1">5%</td><td colspan="20" align="center" rowspan="1">64.3%</td><td colspan="20" align="center" rowspan="1">26.2%</td><td colspan="20" align="center" rowspan="1">4.5%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1">Thrombus</td><td colspan="12" align="center" rowspan="1">None</td><td colspan="12" align="center" rowspan="1">&#x0003c;25%</td><td colspan="12" align="center" rowspan="1">25-50%</td><td colspan="12" align="center" rowspan="1">50-75%</td><td colspan="12" align="center" rowspan="1">&#x0003e;75%</td><td colspan="12" align="center" rowspan="1">None</td><td colspan="12" align="center" rowspan="1">&#x0003c;25%</td><td colspan="12" align="center" rowspan="1">25-50%</td><td colspan="12" align="center" rowspan="1">50-75%</td><td colspan="12" align="center" rowspan="1">&#x0003e;75%</td><td colspan="12" align="center" rowspan="1">None</td><td colspan="12" align="center" rowspan="1">&#x0003c;25%</td><td colspan="12" align="center" rowspan="1">25-50%</td><td colspan="12" align="center" rowspan="1">50-75%</td><td colspan="12" align="center" rowspan="1">&#x0003e;75%</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="12" align="center" rowspan="1">79.2%</td><td colspan="12" align="center" rowspan="1">2.1%</td><td colspan="12" align="center" rowspan="1">6.3%</td><td colspan="12" align="center" rowspan="1">10.4%</td><td colspan="12" align="center" rowspan="1">2.1%</td><td colspan="12" align="center" rowspan="1">63.8%</td><td colspan="12" align="center" rowspan="1">6.9%</td><td colspan="12" align="center" rowspan="1">10.3%</td><td colspan="12" align="center" rowspan="1">17.2%</td><td colspan="12" align="center" rowspan="1">1.7%</td><td colspan="12" align="center" rowspan="1">70.7%</td><td colspan="12" align="center" rowspan="1">4.9%</td><td colspan="12" align="center" rowspan="1">12.2%</td><td colspan="12" align="center" rowspan="1">7.3%</td><td colspan="12" align="center" rowspan="1">4.9%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1"> Angulation</td><td colspan="20" align="center" rowspan="1"> None</td><td colspan="20" align="center" rowspan="1">&#x0003c;50&#x000b0;</td><td colspan="20" align="center" rowspan="1">&#x0003e;50&#x000b0;</td><td colspan="20" align="center" rowspan="1"> None</td><td colspan="20" align="center" rowspan="1">&#x0003c;50&#x000b0;</td><td colspan="20" align="center" rowspan="1">&#x0003e;50&#x000b0;</td><td colspan="20" align="center" rowspan="1"> None</td><td colspan="20" align="center" rowspan="1">&#x0003c;50&#x000b0;</td><td colspan="20" align="center" rowspan="1">&#x0003e;50&#x000b0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="20" align="center" rowspan="1"> 24.5%</td><td colspan="20" align="center" rowspan="1"> 42.9%</td><td colspan="20" align="center" rowspan="1"> 32.7%</td><td colspan="20" align="center" rowspan="1"> 18.6%</td><td colspan="20" align="center" rowspan="1"> 47.5%</td><td colspan="20" align="center" rowspan="1"> 33.9%</td><td colspan="20" align="center" rowspan="1"> 9.5%</td><td colspan="20" align="center" rowspan="1"> 52.4%</td><td colspan="20" align="center" rowspan="1"> 38.1%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1"> Iliac Tortuosity</td><td colspan="20" align="center" rowspan="1"> Small</td><td colspan="20" align="center" rowspan="1"> Medium</td><td colspan="20" align="center" rowspan="1"> Large</td><td colspan="20" align="center" rowspan="1"> Small</td><td colspan="20" align="center" rowspan="1"> Medium</td><td colspan="20" align="center" rowspan="1"> Large</td><td colspan="20" align="center" rowspan="1"> Small</td><td colspan="20" align="center" rowspan="1"> Medium</td><td colspan="20" align="center" rowspan="1"> Large</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="20" align="center" rowspan="1"> 43.2%</td><td colspan="20" align="center" rowspan="1"> 37.8%</td><td colspan="20" align="center" rowspan="1"> 18.9%</td><td colspan="20" align="center" rowspan="1"> 33.3%</td><td colspan="20" align="center" rowspan="1"> 44.4%</td><td colspan="20" align="center" rowspan="1"> 22.2%</td><td colspan="20" align="center" rowspan="1"> 19%</td><td colspan="20" align="center" rowspan="1"> 38.1%</td><td colspan="20" align="center" rowspan="1"> 42.9%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1"> Right CIA Diameter</td><td colspan="30" align="center" rowspan="1">&#x0003c;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003e;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003c;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003e;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003c;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003e;20mm</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="30" align="center" rowspan="1"> 85.7%</td><td colspan="30" align="center" rowspan="1"> 14.3%</td><td colspan="30" align="center" rowspan="1"> 78.9%</td><td colspan="30" align="center" rowspan="1"> 21.1%</td><td colspan="30" align="center" rowspan="1"> 83.3%</td><td colspan="30" align="center" rowspan="1"> 17.7%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1"> Left CIA Diameter</td><td colspan="30" align="center" rowspan="1">&#x0003c;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003e;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003c;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003e;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003c;20mm</td><td colspan="30" align="center" rowspan="1">&#x0003e;20mm</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="30" align="center" rowspan="1"> 72%</td><td colspan="30" align="center" rowspan="1"> 28%</td><td colspan="30" align="center" rowspan="1"> 78.9%</td><td colspan="30" align="center" rowspan="1"> 21.1%</td><td colspan="30" align="center" rowspan="1"> 83.3%</td><td colspan="30" align="center" rowspan="1"> 17.7%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1"> ASA</td><td colspan="20" align="center" rowspan="1"> II</td><td colspan="20" align="center" rowspan="1"> III</td><td colspan="20" align="center" rowspan="1"> IV</td><td colspan="20" align="center" rowspan="1"> II</td><td colspan="20" align="center" rowspan="1"> III</td><td colspan="20" align="center" rowspan="1"> IV</td><td colspan="20" align="center" rowspan="1"> II</td><td colspan="20" align="center" rowspan="1"> III</td><td colspan="20" align="center" rowspan="1"> IV</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="20" align="center" rowspan="1"> 22.6%</td><td colspan="20" align="center" rowspan="1"> 64.2%</td><td colspan="20" align="center" rowspan="1"> 13.2%</td><td colspan="20" align="center" rowspan="1"> 16.1%</td><td colspan="20" align="center" rowspan="1"> 69.4%</td><td colspan="20" align="center" rowspan="1"> 14.5%</td><td colspan="20" align="center" rowspan="1"> 6.4%</td><td colspan="20" align="center" rowspan="1"> 80.9%</td><td colspan="20" align="center" rowspan="1"> 12.7%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="2" colspan="1"> Anaesthesia</td><td colspan="20" align="center" rowspan="1"> General</td><td colspan="20" align="center" rowspan="1"> Local</td><td colspan="20" align="center" rowspan="1"> Loco-regional</td><td colspan="20" align="center" rowspan="1"> General</td><td colspan="20" align="center" rowspan="1"> Local</td><td colspan="20" align="center" rowspan="1"> Loco-regional</td><td colspan="20" align="center" rowspan="1"> General</td><td colspan="20" align="center" rowspan="1"> Local</td><td colspan="20" align="center" rowspan="1"> Loco-regional</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="20" align="center" rowspan="1"> 38%</td><td colspan="20" align="center" rowspan="1"> 0%</td><td colspan="20" align="center" rowspan="1"> 62%</td><td colspan="20" align="center" rowspan="1"> 42.2%</td><td colspan="20" align="center" rowspan="1"> 4.7%</td><td colspan="20" align="center" rowspan="1"> 53.1%</td><td colspan="20" align="center" rowspan="1"> 23.4%</td><td colspan="20" align="center" rowspan="1"> 6.4%</td><td colspan="20" align="center" rowspan="1"> 70.2%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Length of Stay</td><td colspan="60" align="center" rowspan="1"> 7.2 days (min 2 ; max 60)</td><td colspan="60" align="center" rowspan="1"> 6.17 days (min 1 ; max 40)</td><td colspan="60" align="center" rowspan="1"> 5.54 days (min 2 ; max 15)</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Re-Intervention</td><td colspan="60" align="center" rowspan="1"> 9.3%</td><td colspan="60" align="center" rowspan="1"> 21.2%</td><td colspan="60" align="center" rowspan="1"> 17.6%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">30-day Mortality</td><td colspan="60" align="center" rowspan="1"> 0%</td><td colspan="60" align="center" rowspan="1"> 0%</td><td colspan="60" align="center" rowspan="1"> 3.9%</td></tr></tbody></table></table-wrap><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Atherosclerotic risk factors, cerebrovascular disease, peripheral arterial
disease and body mass index (kg/m<sup>2</sup>), by age group.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="40%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/><col width="15%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th colspan="2" align="left" rowspan="1">&#x000a0;</th><th colspan="3" align="center" rowspan="1"> Age groups</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th></tr><tr style="border-right:hidden;border-left:hidden"><th colspan="2" align="left" rowspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x0003c; 70 years</th><th align="center" rowspan="1" colspan="1">70-80 years</th><th align="center" rowspan="1" colspan="1">&#x0003e; 80 years</th><th align="center" rowspan="1" colspan="1">SS</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">83.3%</td><td align="center" rowspan="1" colspan="1">90.9%</td><td align="center" rowspan="1" colspan="1">76.5%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Active smokers</td><td align="center" rowspan="1" colspan="1">38.9%</td><td align="center" rowspan="1" colspan="1">7.7%</td><td align="center" rowspan="1" colspan="1">3.9%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Former smokers</td><td align="center" rowspan="1" colspan="1">48.1%</td><td align="center" rowspan="1" colspan="1">70.8%</td><td align="center" rowspan="1" colspan="1">54.9%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Dyslipidemia</td><td align="center" rowspan="1" colspan="1">66.7%</td><td align="center" rowspan="1" colspan="1">73.8%</td><td align="center" rowspan="1" colspan="1">60.8%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">20.4%</td><td align="center" rowspan="1" colspan="1">13.8%</td><td align="center" rowspan="1" colspan="1">21.6%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Cerebrovascular disease</td><td align="center" rowspan="1" colspan="1">24.1%</td><td align="center" rowspan="1" colspan="1">26.2%</td><td align="center" rowspan="1" colspan="1">5.9%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td colspan="2" rowspan="1">Peripheral arterial disease</td><td align="center" rowspan="1" colspan="1">18.5%</td><td align="center" rowspan="1" colspan="1">21.5%</td><td align="center" rowspan="1" colspan="1">13.7%</td><td align="center" rowspan="1" colspan="1">N</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="4" colspan="1">Atherosclerotic risk factors association</td><td rowspan="1" colspan="1">No risk factors</td><td align="center" rowspan="1" colspan="1">25%</td><td align="center" rowspan="1" colspan="1">25%</td><td align="center" rowspan="1" colspan="1">25%</td><td rowspan="4" align="center" colspan="1"> N</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">1-2 risk factors</td><td align="center" rowspan="1" colspan="1">32.6%</td><td align="center" rowspan="1" colspan="1">30.2%</td><td align="center" rowspan="1" colspan="1">37.2%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">3-4 risk factors</td><td align="center" rowspan="1" colspan="1">30.9%</td><td align="center" rowspan="1" colspan="1">41.5%</td><td align="center" rowspan="1" colspan="1">27.7%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">5 or + risk factors</td><td align="center" rowspan="1" colspan="1">38.9%</td><td align="center" rowspan="1" colspan="1">55.6%</td><td align="center" rowspan="1" colspan="1">5.6%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="3" colspan="1">BMI</td><td rowspan="1" colspan="1">&#x0003c; 25 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">30.6%</td><td align="center" rowspan="1" colspan="1">34%</td><td align="center" rowspan="1" colspan="1">60.4%</td><td rowspan="3" align="center" colspan="1"><italic>P</italic>=0.06</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">25-30 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">38.8%</td><td align="center" rowspan="1" colspan="1">41.5%</td><td align="center" rowspan="1" colspan="1">33%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x0003e; 30 kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">30.6%</td><td align="center" rowspan="1" colspan="1">24.5%</td><td align="center" rowspan="1" colspan="1">17.7%</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>SS =statistical significance; Y=yes; N=no</p></fn></table-wrap-foot></table-wrap><p>Regarding erectile function, 44.6% patients, with mean age of 75.5&#x000b1;7.2 years,
presented dysfunction pre-EVAR, compared to 55.4% patients with erectile function
preserved, with a mean age of 70&#x000b1;8.7 years. This age difference was
statistically significant (<italic>P</italic>&#x0003c;0.05). Grouping erectile
dysfunction by age, there is an obvious tendency for it to increase with age (<xref ref-type="fig" rid="f1">Figure 1</xref>). The need for blood transfusion during
hospitalization was also higher in older patients, as shown in <xref ref-type="fig" rid="f2">Figure 2</xref>, and this difference was statistically significant
(<italic>P</italic>&#x0003c;0.05).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Pre-EVAR erectile dysfunction by age group; P=0.074.</p></caption><graphic xlink:href="rbccv-31-02-0132-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Blood transfusion during hospitalization by age group, P=0.04.</p></caption><graphic xlink:href="rbccv-31-02-0132-g02"/></fig>
</p><p>Indications for EVAR were divided in a high-risk profile (clinical + hostile
abdomen), surgeon's option, and patient's option. In the under-70 age group, the
decisions were 73.6%, 15.1%, and 11.3%, respectively; in the 70-80 age group, they
were 80%, 12.3%, and 7.7%, respectively, and in the age &#x0003e;80 group they were 98%,
2%, and 0%, respectively. There was a statistically significant difference among the
age groups and indication for EVAR: in the younger group, the surgeons' and the
patients' options were more frequent. The types of endografts used are described in
<xref ref-type="table" rid="t3">Table 3</xref>.</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Type of endograft used.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="10%" span="1"/><col width="10%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="10%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="10%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/><col width="5%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th colspan="5" align="center" rowspan="1">&#x0003c; 70 years</th><th colspan="5" align="center" rowspan="1"> 70-80 years</th><th colspan="5" align="center" rowspan="1">&#x0003e; 80 years</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="3" align="center" colspan="1">Endograft</td><td rowspan="2" align="center" colspan="1"> Excluder</td><td colspan="2" align="center" rowspan="1">Endurant</td><td colspan="2" align="center" rowspan="1">Talent</td><td rowspan="2" align="center" colspan="1"> Excluder</td><td colspan="2" align="center" rowspan="1">Endurant</td><td colspan="2" align="center" rowspan="1">Talent</td><td rowspan="2" align="center" colspan="1"> Excluder</td><td colspan="2" align="center" rowspan="1">Endurant</td><td colspan="2" align="center" rowspan="1">Talent</td></tr><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">Bi-Iliac</td><td align="center" rowspan="1" colspan="1">Uni-Iliac</td><td align="center" rowspan="1" colspan="1">Bi-Iliac</td><td align="center" rowspan="1" colspan="1">Uni-Iliac</td><td align="center" rowspan="1" colspan="1">Bi-Iliac</td><td align="center" rowspan="1" colspan="1">Uni-Iliac</td><td align="center" rowspan="1" colspan="1">Bi-Iliac</td><td align="center" rowspan="1" colspan="1">Uni-Iliac</td><td align="center" rowspan="1" colspan="1">Bi-Iliac</td><td align="center" rowspan="1" colspan="1">Uni-Iliac</td><td align="center" rowspan="1" colspan="1">Bi-Iliac</td><td align="center" rowspan="1" colspan="1">Uni-Iliac</td></tr><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">42.59%</td><td align="center" rowspan="1" colspan="1">25.93%</td><td align="center" rowspan="1" colspan="1">16.6%</td><td align="center" rowspan="1" colspan="1">1.85%</td><td align="center" rowspan="1" colspan="1">7.41%</td><td align="center" rowspan="1" colspan="1">36.29%</td><td align="center" rowspan="1" colspan="1">32.31%</td><td align="center" rowspan="1" colspan="1">21.54%</td><td align="center" rowspan="1" colspan="1">4.62%</td><td align="center" rowspan="1" colspan="1">4.62%</td><td align="center" rowspan="1" colspan="1">24.49%</td><td align="center" rowspan="1" colspan="1">57%</td><td align="center" rowspan="1" colspan="1">22.45%</td><td align="center" rowspan="1" colspan="1">6.12%</td><td align="center" rowspan="1" colspan="1">14.29%</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>No statistical significance.</p></fn></table-wrap-foot></table-wrap><p>Anatomic risk factors for EVAR were defined as a neck angle &#x0003e;50&#x000ba;, a neck diameter
&#x0003e;28 mm, a neck length &#x0003c;10 mm, calcification of &#x0003e;50% of the neck
circumference, thrombus &#x0003e;50% of the neck circumference, iliac diameter &#x0003e;20 mm,
and iliac tortuosity. In <xref ref-type="fig" rid="f3">Figure 3</xref>, we divided
the number of risk factors presented into 0, 1, and 2 or more risk factors by age
groups. No significant relationship was found between risk factors and age
groups.</p><p>
<fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>EVAR risk factors association by age group; no statistical
significance.</p></caption><graphic xlink:href="rbccv-31-02-0132-g03"/></fig>
</p><p>We reported no statistical difference in the incidence and type of endoleak, as shown
in <xref ref-type="table" rid="t4">Tables 4</xref> and <xref ref-type="table" rid="t5">5</xref>, or in aneurysmal sac behavior (<xref ref-type="table" rid="t6">Table 6</xref>).</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>Presence of endoleak by age group.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="34%" span="1"/><col width="32%" span="1"/><col width="34%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th align="left" rowspan="1" colspan="1">Age group</th><th align="left" rowspan="1" colspan="1">No endoleak</th><th align="left" rowspan="1" colspan="1">With endoleak</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x0003c;70 years</td><td align="center" rowspan="1" colspan="1">63%</td><td align="center" rowspan="1" colspan="1">37%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">70-80 years</td><td align="center" rowspan="1" colspan="1">56.3%</td><td align="center" rowspan="1" colspan="1">43.7%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x0003e;80 years</td><td align="center" rowspan="1" colspan="1">59.6%</td><td align="center" rowspan="1" colspan="1">40.4%</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p>No statistical significance.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5" orientation="portrait" position="float"><label>Table 5</label><caption><p>Type of endoleak by age group.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th align="center" rowspan="1" colspan="1">Age Group</th><th align="center" rowspan="1" colspan="1">No endoleak</th><th align="center" rowspan="1" colspan="1">Endoleak I or III</th><th align="center" rowspan="1" colspan="1">Endoleak II</th><th align="center" rowspan="1" colspan="1">Endoleak II + I/III</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">&#x0003c;70 years</td><td align="center" rowspan="1" colspan="1">63%</td><td align="center" rowspan="1" colspan="1">3.7%</td><td align="center" rowspan="1" colspan="1">25.9%</td><td align="center" rowspan="1" colspan="1">7.4%</td></tr><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">70-80 years</td><td align="center" rowspan="1" colspan="1">56.3%</td><td align="center" rowspan="1" colspan="1">12.5%</td><td align="center" rowspan="1" colspan="1">28.1%</td><td align="center" rowspan="1" colspan="1">3.1%</td></tr><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">&#x0003e;80 years</td><td align="center" rowspan="1" colspan="1">59.6%</td><td align="center" rowspan="1" colspan="1">12.8%</td><td align="center" rowspan="1" colspan="1">19.1%</td><td align="center" rowspan="1" colspan="1">8.5%</td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p>No statistical significance.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t6" orientation="portrait" position="float"><label>Table 6</label><caption><p>Aneuysmal sac behavior after EVAR</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="28%" span="1"/><col width="24%" span="1"/><col width="24%" span="1"/><col width="24%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x0003c;70 years</th><th align="center" rowspan="1" colspan="1">70-80 years</th><th align="center" rowspan="1" colspan="1">&#x0003e;80 years</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Sac growth</td><td align="center" rowspan="1" colspan="1">8.0%</td><td align="center" rowspan="1" colspan="1">11.3%</td><td align="center" rowspan="1" colspan="1">13.3%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">Sac shrinkage</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">0-5 mm</td><td align="center" rowspan="1" colspan="1">26.0%</td><td align="center" rowspan="1" colspan="1">16.1%</td><td align="center" rowspan="1" colspan="1">24.4%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">5-10 mm</td><td align="center" rowspan="1" colspan="1">30.0%</td><td align="center" rowspan="1" colspan="1">32.3%</td><td align="center" rowspan="1" colspan="1">33.3%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">10-15 mm</td><td align="center" rowspan="1" colspan="1">6.0%</td><td align="center" rowspan="1" colspan="1">14.5%</td><td align="center" rowspan="1" colspan="1">17.8%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">15-20 mm</td><td align="center" rowspan="1" colspan="1">8.0%</td><td align="center" rowspan="1" colspan="1">14.5%</td><td align="center" rowspan="1" colspan="1">4.4%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">20-25 mm</td><td align="center" rowspan="1" colspan="1">8.0%</td><td align="center" rowspan="1" colspan="1">6.5%</td><td align="center" rowspan="1" colspan="1">2.2%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">25-30 mm</td><td align="center" rowspan="1" colspan="1">8.0%</td><td align="center" rowspan="1" colspan="1">1.6%</td><td align="center" rowspan="1" colspan="1">2.2%</td></tr><tr style="border-right:hidden;border-left:hidden"><td rowspan="1" colspan="1">&#x0003e;30 mm</td><td align="center" rowspan="1" colspan="1">6.0%</td><td align="center" rowspan="1" colspan="1">3.2%</td><td align="center" rowspan="1" colspan="1">2.2%</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>No statistical significance.</p></fn></table-wrap-foot></table-wrap><p>Two deaths were registered on the 30<sup>th</sup> day of the follow-up period, both
in the &#x0003e;80 age group. The global mortality rate was 1.2% (2/171).</p><p><xref ref-type="fig" rid="f4">Figure 4</xref> presents 12-year cumulative survival
after EVAR. Estimating the effect of age, we found that survival in the youngest age
group (&#x0003e;70 years) was higher but with no statistical significance.</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>In the population below 70 years, the median survival were 9.9 years,
standard deviation 0.7 (CI 95 - 8.5 to 11.2). The population with 70-80
years had a median survival of 7.2 years, standard deviation 0.7 (CI 95
- 5.8 to 8.6). The patients older than 80 years had a median survival of
8.3 years, standard deviation 1 (CI 95 - 6.4 to 10.3).</p></caption><graphic xlink:href="rbccv-31-02-0132-g04"/></fig>
</p><p>The mean procedure cost for patients with &#x0003c;70 years was 11.658&#x020ac;, for
patients between 70-80 years was 11.110,3&#x020ac;, and for patients with &#x0003e;80
years, the cost was 11.521,8&#x020ac; (<xref ref-type="table" rid="t7">Table
7</xref>).</p><table-wrap id="t7" orientation="portrait" position="float"><label>Table 7</label><caption><p>Mean operative costs for patients undergoing EVAR.</p></caption><table frame="box" rules="all"><colgroup span="1"><col width="16%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr style="border-right:hidden;border-left:hidden"><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Mean</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">Std. Deviation</th><th align="center" rowspan="1" colspan="1">Minimum</th><th align="center" rowspan="1" colspan="1">Maximum</th></tr></thead><tbody><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">EVAR</td><td align="center" rowspan="1" colspan="1">&#x0003c;70 years</td><td align="center" rowspan="1" colspan="1">11,658 &#x020ac;</td><td align="center" rowspan="1" colspan="1">10,226.80 &#x020ac;</td><td align="center" rowspan="1" colspan="1">6,157.80 &#x020ac;</td><td align="center" rowspan="1" colspan="1">9,270 &#x020ac;</td><td align="center" rowspan="1" colspan="1">50,779.70 &#x020ac;</td></tr><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">70-80 years</td><td align="center" rowspan="1" colspan="1">11,110.30 &#x020ac;</td><td align="center" rowspan="1" colspan="1">10,484.70 &#x020ac;</td><td align="center" rowspan="1" colspan="1">2,163 &#x020ac;</td><td align="center" rowspan="1" colspan="1">9,433 &#x020ac;</td><td align="center" rowspan="1" colspan="1">20,979 &#x020ac;</td></tr><tr style="border-right:hidden;border-left:hidden"><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x0003e;80 years</td><td align="center" rowspan="1" colspan="1">11,521.80 &#x020ac;</td><td align="center" rowspan="1" colspan="1">10,371.30 &#x020ac;</td><td align="center" rowspan="1" colspan="1">4,752.80 &#x020ac;</td><td align="center" rowspan="1" colspan="1">9,081.50 &#x020ac;</td><td align="center" rowspan="1" colspan="1">40,240.70 &#x020ac;</td></tr></tbody></table><table-wrap-foot><fn id="TFN6"><p>No statistical significance.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>It is the consensus that EVAR is indicated in elderly and highrisk patients. However,
in light of good results, the indication for EVAR has been progressively extended to
younger and less highrisk patients, and also to patients with added anatomical
risks. So, it is fair to question if age is an important factor in choosing EVAR as
the best therapeutic choice.</p><p>EVAR growth has been overwhelming. Albuquerque et al.<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup> documented a significant increase in the number of
EVARs performed between 2005 and 2008, with an average rate of 84%, compared to a
rate of 42.2% between 1996 and 2002. Schwarze et al.<sup>[<xref rid="r7" ref-type="bibr">7</xref>]</sup> reported a 162% increase for patients &#x0003e;85 years
old between 2001 and 2006. For those younger (50-64 years old), the increase was
less pronounced. Still, in 2005 and 2006, for this age group EVAR was already a
commonly chosen procedure.</p><p>A factor to consider when choosing a therapy is the life expectancy of this group of
patients. Altaf et al.<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup> mentioned
that independently of the technique used in AAA treatment, in young patients, the
mortality rate in 6 years was 40%, with most of the deaths unrelated to the
aneurysm. Darwood et al.<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup> stated
that the group of patients with aneurysms 4-5.4 cm in diameter diagnosed by a
screening in Gloucestershire had a 10-year mortality of 58%. Therefore, the survival
rate of the patient with an AAA can be much lower than that of the general
population.</p><p>Mani et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>, using the Swedish
Vascular Registry from 1987 to 2005, published a 5-year survival rate of 69% and a
10-year survival rate of 39.3% after elective correction of AAAs. Mean survival was
8.9 years (99% CI: 8.7-9.2). No significant difference in relative survival was
observed among different age groups. In our study, we estimated survival curves of
9.9 years for those younger than 70 years, 7.2 years for those aged 70-80 years, and
8.3 years for the elderly, those over 80 years old.</p><p>The published randomized trials EVAR-1<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>, DREAM<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>, and OVER<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>, comparing EVAR with conventional
surgery, showed that early death rates were lower with EVAR (1.7% vs. 4.7%, P=0.009;
1.2% vs. 4.6%, P=0.10; and 0.5% vs. 3%, P=0.004, respectively). EVAR-1<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup> showed higher reintervention
rates, all graft related (23.2% vs. 8.9%, <italic>P</italic>&#x0003c;0.001). The OVER
study included laparotomy-related complications (incisional hernia, bowel ischemia
or obstruction) and showed similar reintervention rates (22.1% vs. 17.8%,
<italic>P</italic>=0.12); the time to a secondary therapeutic procedure or death
was also similar (1.06 years, <italic>P</italic>=0.57).</p><p>The ACE study showed a death rate higher with EVAR compared to conventional surgery
(1.6% vs. 0.6%, P=0.09, not statistically significant) and a higher reintervention
rate (16% vs. 2.7%, <italic>P</italic>&#x0003c;0.0001), but reinterventions for
incisional repair were not recorded<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>In our study, a global mortality of 1.2% (very similar to the mortality rates
published in the literature after EVAR) was noted. By age group, zero mortality was
noted in both the &#x0003c;70 and 70-80 age groups, and two deaths were registered in the
&#x0003e;80 age group (2/51, 3.9%). Although not statistically significant, the trend to
lower mortality suggested the safety of EVAR in younger people.</p><p>Reinterventions seem to be more frequent after EVAR, but the majority are minor
endovascular reinterventions with relatively low 30-day mortality, as stated by
Giles et al.<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>. Recently, Lee et
al.<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup> described a
nonsignificant difference in the reintervention rate between EVAR (16%) and
conventional surgery (12%) in a single center retrospective review. In our study,
there was no statistical difference in reinterventions among different age groups.
Indeed, the number of reinterventions was smaller in younger groups: 9.3% (&#x0003c;70
years old), 21.2% (70-80 years old), and 17.6% (&#x0003e;80 years old).</p><p>The EVAR-2 study compared a set of patients unfit for open repair<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. This study is the closest to our
experience, as the majority of our patients submitted to EVAR had clinical
contraindications for open surgery. In EVAR-2 this group was submitted to EVAR or
underwent clinical follow-up. This study showed a higher death rate with EVAR
compared to the EVAR-1 study (9% vs. 2.1%). However, Lim et al.<sup>[<xref rid="r15" ref-type="bibr">15</xref>]</sup>, applying the same criteria as
EVAR-2, had mortality rates much lower and similar to the remaining literature.</p><p>The population study made by Schernerhorn et al.<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup> comparing EVAR with open repair revealed a mortality rate
of 1.2% vs. 4.8%, respectively. The benefits of EVAR were still present after three
years of follow-up, when both procedures' results were matched. In the
64-74-year-old age, the results are comparable after the first year, while in the
group of patients over 85 years old there was still an advantage for the EVAR
procedure in the fourth year.</p><p>The indication for EVAR in young patients can be questioned after Schanzer's et
al.<sup>[<xref rid="r17" ref-type="bibr">17</xref>]</sup> publication. This
analysis revealed that 5 years after EVAR, there was aneurysm sac growth over 5 mm
in 41% of patients. The predisposing factors to this growth were conical aortic
neck, aortic neck diameter &#x0003e;28 mm, neck angle &#x0003e;60&#x000ba;, iliac diameter &#x0003e;20 mm,
and the presence of an endoleak. As younger patients had a longer life expectancy,
it seems to also present a higher risk of sac growth. However, in this study, the
primary determinant of AAA sac enlargement was the presence of an endoleak, and the
majority of endoleaks (76%) became evident during the first year post-EVAR. Besides,
analyzing additional significant predictors of AAA sac enlargement in a
multivariable analysis in those over 80 years old, age was also considered one
predisposing risk factor. In our study, there was no significant difference in sac
enlargement between older and younger patients.</p><p>In our study, considering the retirement age in the public sector (70 years) and life
expectancy in Portugal (81 years, according to the Global Health Observatory Data
Repository, 2012, <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gho/data/node.main.688?lang=en">http://apps.who.int/gho/data/node.main.688?lang=en</ext-link>), patients under
70 were considered young.</p><p>In contrast to randomized studies, with carefully selected patients, ours is a
real-life study with all consecutive patients submitted to EVAR. There is a relevant
difference in ASA physical status classification among our patients and others
mentioned above. We can classify our population as ASA I (0%), ASA II (15.4%), ASA
III (71%), and &#x0003e; ASA IV (13.6%), compared to 10.6%, 65.6%, 22.5%, and 1.3%,
respectively, as reported by the ACE trials<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup> and 21.4%, 70.5%, 8.1%, and 0%, as described by the DREAM
group<sup>[<xref rid="r18" ref-type="bibr">18</xref>]</sup>.</p><p>Therapeutic choice was based on a set of parameters such as the surgical risk (both
clinical and anatomic), the anatomical characteristics of the aneurysm, and the
surgeon's and patient's option. Winterborn et al.<sup>[<xref rid="r19" ref-type="bibr">19</xref>]</sup>, after a semistructured telephone interview with
patients with small AAAs, concluded that the majority would prefer EVAR. Their major
fears were the risk of organ failure and death. The type of incision, radiation
exposure, and the risk of sexual dysfunction were ranked as the least important.
Another three studies placed EVAR first among patients' preferences, for whom lower
short-term morbidity and mortality and a shorter length of stay took precedence over
a higher risk of future reinterventions<sup>[<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r21" ref-type="bibr">21</xref>]</sup>. In our study,
the surgeons' and patients' preferences for EVAR were statistically relevant in the
younger group.</p><p>Another factor was relevant among age groups, and it may have had an impact on
therapeutic choice: erectile dysfunction was significantly more frequent in older
patients. As described elsewhere, sexual function deterioration is more frequent
after open surgery<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. So, we can
assume that for younger patients, with preserved sexual activity, EVAR could be a
better solution, as long as the internal iliac artery is preserved, as it does not
interfere with parasympathetic chains and has a lower risk of producing sexual
dysfunction.</p><p>During hospitalization, older patients needed a great number of blood transfusions.
This difference was statistically significant and may suggest lower rates of early
complications in younger patients. We haven't observed different costs between
different age groups.</p><p>Obesity is a known risk factor for open surgery, and it is associated with worse
outcomes. As published in a meta-analysis, after a review of 4 studies with a total
of 2440 patients, 30-day postoperative mortality was statistically higher with open
surgery, as was myocardial infarction, chest infection, renal failure, and wound
infection, compared to obese patients submitted to EVAR<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. In our study, one-third of the younger group was
obese and, in these patients, EVAR is favored over open surgery.</p><p>Veith et al.<sup>[<xref rid="r24" ref-type="bibr">24</xref>]</sup>, arguing against
level 1 studies, had no doubts: in fit patients with suitable anatomy, and when
performed with requisite skills, facilities, and equipment, "do it by endovascular
aneurysm repair!". Their position is based on several points: first, we do it better
than we did it when we started, so the actual results are better than those
published 10 years ago, and we still considered level 1 evident (EVAR-1, OVER);
second, endoprotheses are better, with lower migration and late failure and,
finally, now we know and understand complications and we treat them in a useful time
period (in EVAR-1, all endoleaks were considered complications and many
complications were detected but left untreated). Also EVAR processing technical
details have been improved, as recently stated by Molinari et al.<sup>[<xref rid="r25" ref-type="bibr">25</xref>]</sup>, who concluded that as time goes
by, the level of performance has increased and interventional procedures are done
more efficiently, with less contrast injections and exposure to ionizing
radiation.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Analyzing our experience, the absence of statistical differences between mortality
and reinterventions between different age groups reveals that age itself is not a
relevant factor in EVAR outcomes. Indeed, the three characteristics statistically
different in younger patients (obesity, sexual function, and patient's choice) can
favour EVAR. No other clinical variables, surgical reintervention, mortality or
costs were statistically different among age groups. Thus, we can suggest that age
is not important as association to procedure-related EVAR outcomes when compared to
older patients, and thereby may not be decisive in surgeon's choice towards EVAR in
a younger population; however, the limitations of the retrospective analysis must be
considered.</p><table-wrap id="t9" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th colspan="2" align="left" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td valign="top" rowspan="1" colspan="1">RM</td><td rowspan="1" colspan="1">Conception and design study; operations and/or trials performance;
analysis and/or data interpretation; manuscript writing or critical
review of its content; final manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">GT</td><td rowspan="1" colspan="1">Manuscript writing or critical review of its content; final
manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">PO</td><td rowspan="1" colspan="1">Statistical analysis; final manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">LL</td><td rowspan="1" colspan="1">Operations and/or trials performance; final manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">CP</td><td rowspan="1" colspan="1">Operations and/or trials performance; final manuscript approval</td></tr><tr><td valign="top" rowspan="1" colspan="1">RA</td><td rowspan="1" colspan="1">Final manuscript approval</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="COI-statement"><p>The authors declared no conflicts of interest.</p></fn><fn fn-type="supported-by"><p>No financial support.</p></fn><fn fn-type="other"><p>This study was carried out at Hospital de Santo Ant&#x000f3;nio - Centro Hospitalar do
Porto, Porto, Portugal.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parodi</surname><given-names>JC</given-names></name><name><surname>Palmaz</surname><given-names>JC</given-names></name><name><surname>Barone</surname><given-names>HD</given-names></name></person-group><article-title>Transfemoral intraluminal graft implantation for abdominal aortic
aneurysms</article-title><source>Ann Vasc Surg</source><year>1991</year><volume>5</volume><issue>6</issue><fpage>491</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">1837729</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenhalgh</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>LC</given-names></name><name><surname>Kwong</surname><given-names>GP</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><collab>EVAR trial participants</collab></person-group><article-title>Comparison of endovascular aneurysm repair with open repair in
patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative
mortality results: randomised controlled trial</article-title><source>Lancet</source><year>2004</year><volume>364</volume><issue>9437</issue><fpage>843</fpage><lpage>848</lpage><pub-id pub-id-type="pmid">15351191</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinssen</surname><given-names>M</given-names></name><name><surname>Verhoeven</surname><given-names>EL</given-names></name><name><surname>Buth</surname><given-names>J</given-names></name><name><surname>Cuypers</surname><given-names>PW</given-names></name><name><surname>van Sambeek</surname><given-names>MR</given-names></name><name><surname>Balm</surname><given-names>R</given-names></name><etal/><collab>Dutch Randomized Endovascular Aneurysm Management Trial
Group</collab></person-group><article-title>A randomized trial comparing conventional and endovascular repair
of abdominal aortic aneurysms</article-title><source>N Engl J Med</source><year>2004</year><volume>351</volume><issue>16</issue><fpage>1607</fpage><lpage>1618</lpage><pub-id pub-id-type="pmid">15483279</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lederle</surname><given-names>FA</given-names></name><name><surname>Freischlag</surname><given-names>JA</given-names></name><name><surname>Kyriakides</surname><given-names>TC</given-names></name><name><surname>Matsumura</surname><given-names>JS</given-names></name><name><surname>Padberg</surname><given-names>FT Jr</given-names></name><name><surname>Kohler</surname><given-names>TR</given-names></name><etal/><collab>OVER Veterans Affairs Cooperative Study Group</collab></person-group><article-title>Long-term comparison of endovascular and open repair of abdominal
aortic aneurysm</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><issue>21</issue><fpage>1988</fpage><lpage>1997</lpage><pub-id pub-id-type="pmid">23171095</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becquemin</surname><given-names>JP</given-names></name><name><surname>Pillet</surname><given-names>JC</given-names></name><name><surname>Lescalie</surname><given-names>F</given-names></name><name><surname>Sapoval</surname><given-names>M</given-names></name><name><surname>Goueffic</surname><given-names>Y</given-names></name><name><surname>Lermusiaux</surname><given-names>P</given-names></name><etal/><collab>ACE trialists</collab></person-group><article-title>A randomized controlled trial of endovascular aneurysm repair
versus open surgery for abdominal aortic aneurysms in low- to moderate-risk
patients</article-title><source>J Vasc Surg</source><year>2011</year><volume>53</volume><issue>5</issue><fpage>1167</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">21276681</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albuquerque Jr</surname><given-names>FC</given-names></name><name><surname>Tonnessen</surname><given-names>BH</given-names></name><name><surname>Noll Jr</surname><given-names>RE</given-names></name><name><surname>Cires</surname><given-names>G</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Sternbergh 3rd</surname><given-names>WC</given-names></name></person-group><article-title>Paradigm shifts in the treatment of abdominal aortic aneurysm:
trends in 721 patients between 1996 and 2008</article-title><source>J Vasc Surg</source><year>2010</year><volume>51</volume><issue>6</issue><fpage>1348</fpage><lpage>1352</lpage><pub-id pub-id-type="pmid">20488317</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarze</surname><given-names>ML</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Hemmerich</surname><given-names>J</given-names></name><name><surname>Dale</surname><given-names>W</given-names></name></person-group><article-title>Age-related trends in utilization and outcome of open and
endovascular repair for abdominal aortic aneurysm in the United States,
2001-2006</article-title><source>J Vasc Surg</source><year>2009</year><volume>50</volume><issue>4</issue><fpage>722</fpage><lpage>729</lpage><pub-id pub-id-type="pmid">19560313</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altaf</surname><given-names>N</given-names></name><name><surname>Abisi</surname><given-names>S</given-names></name><name><surname>Yong</surname><given-names>Y</given-names></name><name><surname>Saunders</surname><given-names>JH</given-names></name><name><surname>Braithwaite</surname><given-names>BD</given-names></name><name><surname>MacSweeney</surname><given-names>ST</given-names></name></person-group><article-title>Mid-term results of endovascular aortic aneurysm repair in the
young</article-title><source>Eur J Vasc Endovasc Surg</source><year>2013</year><volume>46</volume><issue>3</issue><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">23683396</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Darwood</surname><given-names>R</given-names></name><name><surname>Earnshaw</surname><given-names>JJ</given-names></name><name><surname>Turton</surname><given-names>G</given-names></name><name><surname>Shaw</surname><given-names>E</given-names></name><name><surname>Whyman</surname><given-names>M</given-names></name><name><surname>Poskitt</surname><given-names>K</given-names></name><etal/></person-group><article-title>Twenty-year review of abdominal aortic aneurysm screening in men
in the county of Gloucestershire, United Kingdom</article-title><source>J Vasc Surg</source><year>2012</year><volume>56</volume><issue>1</issue><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">22503187</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mani</surname><given-names>K</given-names></name><name><surname>Bj&#x000f6;rck</surname><given-names>M</given-names></name><name><surname>Lundkvist</surname><given-names>J</given-names></name><name><surname>Wanhainen</surname><given-names>A</given-names></name></person-group><article-title>Improved long-term survival after abdominal aortic aneurysm
repair</article-title><source>Circulation</source><year>2009</year><volume>120</volume><issue>3</issue><fpage>201</fpage><lpage>211</lpage><pub-id pub-id-type="pmid">19581497</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>United Kingdom EVAR Trial Investigators</collab><name><surname>Greenhalgh</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>LC</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name><name><surname>Thompson</surname><given-names>SG</given-names></name><name><surname>Epstein</surname><given-names>D</given-names></name><name><surname>Sculpher</surname><given-names>MJ</given-names></name></person-group><article-title>Endovascular versus open repair of abdominal aortic
aneurysm</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><issue>20</issue><fpage>1863</fpage><lpage>1871</lpage><pub-id pub-id-type="pmid">20382983</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giles</surname><given-names>KA</given-names></name><name><surname>Landon</surname><given-names>BE</given-names></name><name><surname>Cotterill</surname><given-names>P</given-names></name><name><surname>O'Malley</surname><given-names>AJ</given-names></name><name><surname>Pomposelli</surname><given-names>FB</given-names></name><name><surname>Schermerhorn</surname><given-names>ML</given-names></name></person-group><article-title>Thirty-day mortality and late survival with reinterventions and
readmissions after open and endovascular aortic aneurysm repair in Medicare
beneficiaries</article-title><source>J Vasc Surg</source><year>2011</year><volume>53</volume><issue>1</issue><fpage>6</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">21030195</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>E</given-names></name><name><surname>Dubois</surname><given-names>L</given-names></name><name><surname>Power</surname><given-names>AH</given-names></name><name><surname>DeRose</surname><given-names>G</given-names></name><name><surname>Forbes</surname><given-names>TL</given-names></name></person-group><article-title>Durability and survival are similar after elective endovascular
and open repair of abdominal aortic aneurysms in younger
patients</article-title><source>J Vasc Surg</source><year>2015</year><volume>61</volume><issue>3</issue><fpage>636</fpage><lpage>641</lpage><pub-id pub-id-type="pmid">25457459</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>EVAR trial participants</collab></person-group><article-title>Endovascular aneurysm repair and outcome in patients unfit for
open repair of abdominal aortic aneurysm (EVAR trial 2): randomised
controlled trial</article-title><source>Lancet</source><year>2005</year><volume>365</volume><issue>9478</issue><fpage>2187</fpage><lpage>2192</lpage><pub-id pub-id-type="pmid">15978926</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>S</given-names></name><name><surname>Halandras</surname><given-names>PM</given-names></name><name><surname>Park</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Crisostomo</surname><given-names>P</given-names></name><name><surname>Hershberger</surname><given-names>R</given-names></name><etal/></person-group><article-title>Outcomes of endovascular abdominal aortic aneurysm repair in
high-risk patients</article-title><source>J Vasc Surg</source><year>2015</year><volume>61</volume><issue>4</issue><fpage>862</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">25704411</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schermerhorn</surname><given-names>ML</given-names></name><name><surname>O'Malley</surname><given-names>AJ</given-names></name><name><surname>Jhaveri</surname><given-names>A</given-names></name><name><surname>Cotterill</surname><given-names>P</given-names></name><name><surname>Pomposelli</surname><given-names>F</given-names></name><name><surname>Landon</surname><given-names>BE</given-names></name></person-group><article-title>Endovascular vs. open repair of abdominal aortic aneurysms in the
medicare population</article-title><source>N Engl J Med</source><year>2008</year><volume>358</volume><issue>5</issue><fpage>464</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">18234751</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schanzer</surname><given-names>A</given-names></name><name><surname>Greenberg</surname><given-names>RK</given-names></name><name><surname>Hevelone</surname><given-names>N</given-names></name><name><surname>Robinson</surname><given-names>WP</given-names></name><name><surname>Eslami</surname><given-names>MH</given-names></name><name><surname>Goldberg</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Predictors of abdominal aortic aneurysm sac enlargement after
endovascular repair</article-title><source>Circulation</source><year>2011</year><volume>123</volume><issue>24</issue><fpage>2848</fpage><lpage>2855</lpage><pub-id pub-id-type="pmid">21478500</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bruin</surname><given-names>JL</given-names></name><name><surname>Baas</surname><given-names>AF</given-names></name><name><surname>Buth</surname><given-names>J</given-names></name><name><surname>Prinssen</surname><given-names>M</given-names></name><name><surname>Verhoeven</surname><given-names>EL</given-names></name><name><surname>Cuypers</surname><given-names>PW</given-names></name><etal/><collab>DREAM Study Group</collab></person-group><article-title>Long-term outcome of open or endovascular repair of abdominal
aortic aneurysm</article-title><source>N Engl J Med</source><year>2010</year><volume>362</volume><issue>20</issue><fpage>1881</fpage><lpage>1889</lpage><pub-id pub-id-type="pmid">20484396</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winterborn</surname><given-names>RJ</given-names></name><name><surname>Amin</surname><given-names>I</given-names></name><name><surname>Lyratzopoulos</surname><given-names>G</given-names></name><name><surname>Walker</surname><given-names>N</given-names></name><name><surname>Varty</surname><given-names>K</given-names></name><name><surname>Campbell</surname><given-names>WB</given-names></name></person-group><article-title>Preferences for endovascular (EVAR) or open surgical repair among
patients with abdominal aortic aneurysms under surveillance</article-title><source>J Vasc Surg</source><year>2009</year><volume>49</volume><issue>3</issue><fpage>576</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">19268761</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>PJ</given-names></name><name><surname>Gogalniceanu</surname><given-names>P</given-names></name><name><surname>Murray</surname><given-names>S</given-names></name><name><surname>Poloniecki</surname><given-names>JD</given-names></name><name><surname>Loftus</surname><given-names>IM</given-names></name><name><surname>Thompson</surname><given-names>MM</given-names></name></person-group><article-title>Screened individuals' preferences in the delivery of abdominal
aortic aneurysm repair</article-title><source>Br J Surg</source><year>2010</year><volume>97</volume><issue>4</issue><fpage>504</fpage><lpage>510</lpage><pub-id pub-id-type="pmid">20169573</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reise</surname><given-names>JA</given-names></name><name><surname>Sheldon</surname><given-names>H</given-names></name><name><surname>Earnshaw</surname><given-names>J</given-names></name><name><surname>Naylor</surname><given-names>AR</given-names></name><name><surname>Dick</surname><given-names>F</given-names></name><name><surname>Powell</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Patient preference for surgical method of abdominal aortic
aneurysm repair: postal survey</article-title><source>Eur J Vasc Endovasc Surg</source><year>2010</year><volume>39</volume><issue>1</issue><fpage>55</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">19775919</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koo</surname><given-names>V</given-names></name><name><surname>Lau</surname><given-names>L</given-names></name><name><surname>McKinley</surname><given-names>A</given-names></name><name><surname>Blair</surname><given-names>P</given-names></name><name><surname>Hood</surname><given-names>J</given-names></name></person-group><article-title>Pilot study of sexual dysfunction following abdominal aortic
aneurysm surgery</article-title><source>J Sex Med</source><year>2007</year><volume>4</volume><issue>4</issue><issue-part>Pt 2</issue-part><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="pmid">17081220</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saedon</surname><given-names>M</given-names></name><name><surname>Mt-Isa</surname><given-names>S</given-names></name><name><surname>Saratzis</surname><given-names>A</given-names></name><name><surname>Leung</surname><given-names>E</given-names></name><name><surname>Mahmood</surname><given-names>A</given-names></name></person-group><article-title>Outcome of open versus endovascular abdominal aortic aneurysm
repair in obese patients: a systemic review and
meta-analysis</article-title><source>Int Angiol</source><year>2015</year><volume>34</volume><issue>1</issue><fpage>9</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">24824839</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Veith</surname><given-names>F</given-names></name><name><surname>Starnes</surname><given-names>B</given-names></name><name><surname>Kwolak</surname><given-names>C</given-names></name><name><surname>Parodi</surname><given-names>J</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Greenhalgh</surname><given-names>RM</given-names></name></person-group><source>Vascular and endovascular challenges update</source><year>2013</year><publisher-loc>London</publisher-loc><publisher-name>BIBA Publishing</publisher-name></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molinari</surname><given-names>GJ</given-names></name><name><surname>Guillaumon</surname><given-names>AT</given-names></name><name><surname>Dalbem</surname><given-names>AM</given-names></name></person-group><article-title>Efficacy analysis of a script-based guide for EVAR execution: is
it possible to reduce patient exposure to contrast, operative time and blood
loss even when advanced technologies are not available?</article-title><source>Braz J Cardiovasc Surg</source><year>2015</year><volume>30</volume><issue>6</issue><fpage>650</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">26934406</pub-id></element-citation></ref></ref-list></back></article>